Evaluating the endothelial glycocalyx from bench to bedside: a translational framework for microvascular assessment

Abstract

The endothelial glycocalyx (eGCX) plays a crucial role in mechanotransduction, maintaining vascular barrier integrity, and facilitating leukocyte–endothelial crosstalk. However, accurately quantifying it is challenging due to fragmented methodologies. As the eGCX is a highly hydrated, labile layer that readily collapses upon chemical fixation and dehydration, reported thickness values span orders of magnitude depending on the specific measurement principle employed. Consequently, relying on single-metric claims risks both false-positive and false-negative conclusions. Compounding this challenge, eGCX composition, morphology, and injury responses vary significantly across organs and vascular beds. This spatial heterogeneity is a factor that standard static in vitro cultures fundamentally fail to recapitulate. To overcome these limitations, we present a cross-platform evaluation framework organized around three orthogonal axes: structure (coverage, penetrability, and component localization), function (permeability and perfusion), and turnover (shedding versus synthesis). We delineate how each readout corresponds to a distinct physical sub-compartment, critically appraising methods that include confocal lectin staining, rapid-freeze electron microscopy (EM), atomic force microscopy (AFM), transendothelial resistance, intravital exclusion-zone imaging, perfused boundary region analysis, and circulating shedding biomarkers. For each platform, including in vitro, in vivo, and clinical settings, we propose minimal yet robust endpoint packages that integrate assay intent, organ context, and hemodynamic covariates. This approach shifts the field toward convergent, translatable inference for eGCX-targeted therapeutics. Beyond cataloguing techniques, the central contribution of this framework is the explicit mapping of each commonly used readout to the specific physical sub-compartment it interrogates, coupled with organ- and vascular-compartment-aware prioritization, so that convergent agreement among orthogonal structural, functional, and turnover measurements—rather than any single value—becomes the basis for falsifiable, translatable inference.